In the coming three years, 20 EU member states are planning to evaluate 108 substances. The authorities have 12 months to evaluate the 21 substances specified for 2018. The aim is to clarify whether these substances pose a risk to people or the environment. If necessary, the registrants will be asked to provide further information on the substance so that authorities can assess the suspected concern.
The European Chemicals Agency (ECHA) is encouraging registrants of the listed substances to coordinate their actions and to contact the evaluating member state. Registrants are also urged to update their dossiers, especially for uses and exposure scenarios. They will have an opportunity to comment before any decision to request further information is taken. Such draft decisions will be reviewed by the other member states and ECHA before the final decision is issued.
The substances are selected for evaluation to clarify the concerns related to their exposure and suspected serious hazard properties: persistent, bioaccumulative and toxic (PBT), carcinogenic, mutagenic and reprotoxic (CMR), or endocrine disruptors in combination with wide dispersive consumer use. Other concerns on the substances may also be identified during evaluation.
Source: ECHA News Release, 20 March 2018